Morizane, S., Yamasaki, K., Mühleisen, B., Kotol, P. F., Murakami, M., Aoyama, Y., . . . Gallo, R. L. (2011). Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands.
Chicago-stil citatMorizane, Shin, Kenshi Yamasaki, Beda Mühleisen, Paul F. Kotol, Masamoto Murakami, Yumi Aoyama, Keiji Iwatsuki, Tissa Hata, och Richard L. Gallo. Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands. 2011.
MLA-referensMorizane, Shin, et al. Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands. 2011.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.